Lakefront Biotherapeutics

    Lakefront Biotherapeutics

    EEURONEXT:GLPG
    - -
    EUR
    - -
    - -
    3.53P/E
    Lakefront Biotherapeutics
    EURONEXT:GLPG
    (Euronext)

    Recent

    price

    - -

    P/E

    ratio

    3.53

    div

    yld

    - -

    ROIC.AI

    2010
    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    2025
    TTM
    EUR
    5.04
    3.63
    5.13
    2.66
    2.3
    1.11
    2.83
    2.57
    5.35
    14.49
    7.35
    3.58
    3.67
    3.64
    4.17
    16.88
    15.84
    Revenue per Share
    0.18
    -1.25
    -0.22
    -0.28
    1.1
    -3.32
    1.18
    -2.34
    -0.56
    2.6
    -4.69
    -1.58
    -3.32
    3.21
    1.12
    4.87
    7.42
    Basic EPS, GAAP
    -0.94
    -0.68
    2.16
    -0.21
    -2.6
    -3.4
    5.13
    -3.12
    -3
    54.9
    -7.97
    -8.58
    -8.19
    -6.45
    -6.08
    -4.12
    -4.71
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    3.17
    1.75
    1.68
    1.89
    3.1
    0.23
    2.44
    0.44
    -1.18
    3.09
    -0.67
    -1.15
    -3.09
    1
    2.41
    7.66
    7.93
    Book Value per Share
    3.81
    2.61
    2.69
    4.17
    6.78
    10.18
    16.58
    20.4
    23.23
    49.48
    40
    39.44
    35.18
    39.43
    40.25
    49.09
    49.38
    Tangible Book Value per Share
    24
    26
    27
    29
    30
    36
    46
    49
    52
    58
    65
    66
    66
    66
    66
    66
    66
    Basic Weighted Avg Shares
    122
    96
    136
    77
    69
    40
    130
    127
    279
    835
    478
    234
    241
    240
    276
    1,112
    1,044
    Sales/Revenue/Turnover
    1.2
    -36.59
    -1.54
    -21.69
    -51.83
    -226.09
    -8.87
    -70.66
    -16.89
    44.17
    -37.37
    -73.2
    -54.32
    -36.82
    -68.33
    45.08
    57.14
    Operating Margin (%)
    12
    12
    9
    8
    5
    3
    4
    4
    5
    12
    19
    35
    66
    44
    45
    56
    - -
    Depreciation Expense
    4
    -33
    -6
    -8
    33
    -118
    54
    -116
    -29
    150
    -305
    -103
    -218
    212
    74
    321
    489
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    0.43
    - -
    - -
    - -
    - -
    - -
    - -
    170.9
    - -
    - -
    0.59
    Effective Tax Rate (%)
    3.57
    -34.52
    -4.2
    -10.54
    47.88
    -299.3
    41.7
    -91.04
    -10.5
    17.95
    -63.89
    -44.04
    -90.36
    88.31
    26.88
    28.85
    46.83
    Profit Margin (%)
    71
    30
    24
    61
    153
    302
    903
    1,026
    1,109
    5,294
    4,734
    4,295
    3,714
    3,433
    3,004
    2,927
    2,960
    Working Capital
    1
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    20
    23
    20
    15
    5
    8
    5
    5
    LT Debt
    149
    118
    118
    167
    206
    365
    759
    1,012
    1,214
    2,876
    2,670
    2,643
    2,526
    2,796
    2,897
    3,236
    3,253
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    -2.03
    - -
    - -
    - -
    - -
    - -
    - -
    2.34
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    90.16
    - -
    - -
    - -
    - -
    - -
    - -
    -397.34
    - -
    - -
    270.87
    Return on Capital (%)
    6.57
    -53.66
    -12.59
    -16.32
    44.95
    -233.52
    90.22
    -173.17
    - -
    - -
    - -
    - -
    - -
    - -
    65.76
    96.63
    182.59
    Return on Common Equity (%)

    Capital Structure

    EUR

    •

    in mil. unless spec.
    Sep'25
    Dec'25
    Mar'26
    ST Debt
    2
    2
    2
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    6
    5
    5
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    66
    66
    66
    Market Capitalization
    1,920
    1,843
    1,725

    Working Capital

    EUR

    •

    in mil. unless spec.
    Sep'25
    Dec'25
    Mar'26
    Total Current Assets
    3,162
    3,079
    3,061
    Cash, Cash Equivalents & STI
    3,050
    2,998
    2,982
    Accounts Receivable, Net
    45
    10
    22
    Inventories
    23
    22
    18
    Total Current Liabilities
    367
    153
    100
    Payables & Accruals
    101
    34
    97
    ST Debt
    2
    2
    2
    Deferred Revenue
    230
    - -
    - -

    Growth Rates

    EUR

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    31.15%
    4.11%
    11.7%
    Free Cash Flow
    -275.46%
    -10.97%
    -32.53%
    Net Income, GAAP
    -133.45%
    23.2%
    333.15%
    Sales/Revenue/Turnover
    77.15%
    53.96%
    303.5%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    62
    78
    60
    75
    276
    2025
    75
    65
    71
    901
    1,112
    2026
    6
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    1.37
    - -
    - -
    - -
    1.12
    2025
    -2.33
    - -
    - -
    - -
    4.87
    2026
    0.22
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    2026
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business